Spruce Biosciences, Inc. , a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders.
Spruce Biosciences stock last closed at $0.41, down 0.98% from the previous day, and has decreased 91.71% in one year. It has underperformed other stocks in the Biotechnology industry by 0.59 percentage points. Spruce Biosciences stock is currently +18.71% from its 52-week low of $0.34, and -93.18% from its 52-week high of $5.95.
At the moment, there are 41.3M shares of SPRB outstanding. The market value of SPRB is $16.77M. In the last 24 hours, 243,903 SPRB shares were traded.
How to Buy Spruce Biosciences Stock
Not sure how to invest in Spruce Biosciences stock? Here's how.
Choose where to buy Spruce Biosciences stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Spruce Biosciences stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Pick your method of payment and add your details.
Evaluate Spruce Biosciences stock: The Spruce Biosciences ticker symbol is SPRB. Is Spruce Biosciences stock a good investment? Should you buy shares of SPRB? How do SPRB's underlying business fundamentals look? Do top analysts think Spruce Biosciences is a good buy? Why has SPRB's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if SPRB is a good stock to buy).
Make your SPRB buy order: Decide if you will purchase SPRB shares at the current market price or use a limit order to buy SPRB shares at a given price.
Get the latest news on your investment in SPRB: Create a watchlist to track your position in Spruce Biosciences stock.
Step 1: Choose where to buy Spruce Biosciences stock
You will need an online brokerage account to access the NASDAQ market and buy SPRB shares.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to buy SPRB today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Spruce Biosciences stock
Once you have selected the best place to buy Spruce Biosciences stock, it's crucial to evaluate their stock prior to investing, so you truly understand the risk as well as the upside.
Spruce Biosciences shares data
SPRB Price
$0.41
1w %
0%
1y %
-91.71%
5y %
N/A
P/E
-0.43x
P/B
0.32x
P/S
2.36x
PEG
N/A
Revenue
$7.10M
Earnings
-$39.43M
Fore. Rev. Growth
-9.97%
Fore. Earn. Growth
N/A
Market Cap
$16.77M
Next Earnings
Mar 11, 2025
Next Dividend
N/A
Spruce Biosciences Due Diligence Score
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis.
Last year, SPRB revenue was $7.10M. During the last 1 years, SPRB's revenue has grown by -1.4% per year. This was slower than the Biotechnology industry average of 59.48%.
Over the last year, executives and large shareholders at SPRB have sold more shares than they have bought.
Ralph William Charlton Iii, CHIEF MEDICAL OFFICER of SPRB, was the latest SPRB insider to sell. They sold $3,692.00 worth of SPRB stock on Dec 16, 2024.
No, Spruce Biosciences doesn't provide an income stream by paying out dividends.
What others are saying about SPRB
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your SPRB buy order
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the easiest way to buy.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and your broker will place the order.
If you want more help buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Spruce Biosciences share?
As of Feb 14, 2025, it costs $0.41 to buy one share of Spruce Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.2, you can buy 0.5 shares of SPRB.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.